• Nano-Code: 2020-1-BG01-KA226-HE-095017
Partnership Area
What are you looking for?

he-lp1

HE Undergraduates in nanotechnology (EQF 6):

HE-LP1Nanotechnology for antiviral disinfection
SummaryThe mechanisms affecting viral properties and approaches aimed at utilizing viral particle characteristics are presented in this training unit. It also provides information about the importance of ventilation to prevent the transmission of COVID-19, the air filtration systems’ characteristics and their impact on COVID-19 spread. The main features of viral contagiousness are described. The importance of disinfectants and the variety available on the market are revealed. Emphasis is given to the advances in nanotechnology for the inactivation of viruses and control of the COVID-19 epidemic. The emergency of nanoethics as a new bioethical subdiscipline and the nanoethics aspects of mRNA vaccines as genetic engineering products are discussed. Some fields of application of nanomedicine in the surrounding of mRNA technology are also commented in light of COVID-19.
ULOs
Knowledge & Skills		Upon completion of HE-LP1 the trainee will be able to:
  • Know the mail characteristics of viruses and their importance in terms of structure, taxonomy, and mechanism of viral action;
  • Understand the functional nanoparticles and their antiviral activity;
  • Explain the strategies for the construction of Virus-Based Nanoparticles (VNPs) and their application in therapeutic interventions and drug delivery;
  • Present the immunization and immunotherapy approaches based on virus-derived structures.
  • Knows the importance of ventilation to prevent the transmission of COVID-19;
  • Understands the importance of air filtration systems;
  • Understands the features of HEPA filters;
  • Knows that the transmission of COVID-19 can be reduced by filtering systems.
  • Can explain about viruses and their contagiousness;
  • Understands the importance of disinfectants;
  • Knows what commercial disinfectants are;
  • Explain the types of commercial disinfectants;
  • Can explain the use of nanotechnology in PPE.
  • describe the most important tasks of ethical reflection with regard to the application of new technologies using the example of nanotechnology in the field of the development of molecular genetically based vaccines (functions of "nanoethics");
  • understand the basic concerns of technology-related bioethics in the sense of a technology assessment encompassing all social, health and political aspects (risks and chances);
  • distinguish and weight the different issues of bioethics in the field of nanobiotechnology, so that the special problems of "nanoethics" in the medical field become clear;
  • exemplify and discuss the different ethical problems that arise in connection with the development of mRNA vaccines;
CompositionLO 1.1. Viral particles and functional nanomaterials crossing point
LO 2.1. Improved and virus-disabling air filtration systems
LO 2.2. Inanimate surfaces and disinfection methods
LO 6.1. Integration of social and ethical studies into nanotechnology developments
(Self)Assessment HE-LP1 Test
Credit points6
ValidationCertificate
This project has been funded with support from the European Commission. This web-site reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein.